Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Takara Bio Inc. announced a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents ...
read more
Under the agreement terms, the two companies will combine resources to provide the global scientific community with access to custom model design and generation services.
read more
Taconic Biosciences has announced the successful implementation of its Rapid Restart™ program.
read more
Wednesday, October 28, 2020
Taconic Biosciences has announced immediate humanized ACE2 mouse model availability for COVID-19 research.
read more
Taconic Biosciences announced local West Coast United States production of the immunodeficient CIEA NOG mouse® model.
read more
Friday, February 14, 2020
Taconic Biosciences has announced its humanized immune system mice models are now being produced in Europe.
read more
Monday, September 28, 2020
T-knife GmbH and Catalent announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor program.
read more
Wednesday, November 25, 2020
Sysmex America announced it will add the CellaVision® DC-1 to its portfolio of CellaVision products for low-volume hematology labs.
read more
Synthorx announced the appointment of Marcos Milla, Ph.D. as senior vice president of research.
read more
Thursday, September 06, 2018
Synthetic Biologics has entered into an agreement with Cedars-Sinai Medical Center for an investigator-sponsored Phase 2 clinical study of SYN-010.
read more
Synthego Corp., announced the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services.
read more
Wednesday, October 04, 2023
Synthego, a leading provider of genome engineering solutions, announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline.
read more
Synthego announced a partnership with ATCC to provide researchers with an extensive collection of mammalian and mouse cell lines for gene editing applications, including Express Cell Pools to increase speed to results.
read more
Synteract acquired Cu-Tech a dermatology specialist CRO. The two companies have now created a dedicated center of dermatology development.
read more
Wednesday, September 11, 2024
Syntekabio an artificial intelligence (AI)-driven drug development company, announced the appointment of Joonhyuk Choi, former CEO of Target Health, as Head of US Operations.
Joonhyuk brings over 25 years of extensive experience in the ...
read more